Katie McCallum is a PhD candidate at University of Texas Health Science Center at Houston in the Microbiology and Molecular Genetics program. While at the bench, her research is primarily focused on the basic biology governing host-microbial interactions. Katie's research interests extend far beyond the scope of medical microbiology. Her exposure to the enormity of collaborative effort and innovative research that exists in the Texas Medical Center has fostered her interest in science communication and science outreach.
An early benefit assessment indicated that while Portrazza (necitumumab) increases overall patient survival, additional negative effects reduce the impact of this outcome and result in only a minor added benefit for ... Read more
BioMarker Strategies was awarded a Phase 1/2 Fast Track Small Business Innovative Research grant from the National Cancer Institute (NCI) to develop a new biomarker test called PathMAP NSCLC. The diagnostic test will guide individualized ... Read more
The rate of admissions in elderly patients to acute hospital care in the United Kingdom has increased by 65 percent in the last decade, placing increased labor and cost demands on hospital ... Read more
Shire plc, a biotech company focused on therapies for rare diseases and highly specialized conditions, together with Kamada Ltd., a company focused on plasma-derived protein therapeutics for orphan indications, recently secured an expanded label for Glassia from ... Read more